Optimization of paeonol-loaded poly(butyl-2-cyanoacrylate) nanocapsules by central composite design with response surface methodology together with the antibacterial properties
Autor: | Fang Hua, Guan-Hu Bao, Weiyun Wang, Jing-Jing Yao, Decheng Zeng, Yangxin Zhang, Hu Qiming, Meng Wei |
---|---|
Rok vydání: | 2017 |
Předmět: |
Central composite design
Polymers Surface Properties Chemistry Pharmaceutical Ethyl acetate Biological Availability Pharmaceutical Science Nanotechnology Poloxamer 02 engineering and technology 010402 general chemistry 01 natural sciences Nanocapsules chemistry.chemical_compound Response surface methodology Particle Size Chemistry Acetophenones Enbucrilate 021001 nanoscience & nanotechnology Anti-Bacterial Agents 0104 chemical sciences Bioavailability Nanoparticles Particle size Paeonol 0210 nano-technology Nuclear chemistry |
Zdroj: | European Journal of Pharmaceutical Sciences. 101:189-199 |
ISSN: | 0928-0987 |
DOI: | 10.1016/j.ejps.2017.01.028 |
Popis: | With the aim to enhance dissolution rate and bioavailability of paeonol, paeonol-loaded poly(butyl-2-cyanoacrylate) nanocapsules (Pae@PNCs) were prepared by interfacial spontaneous polymerization for the first time. Herein, a rotatable central composite design (RCCD) with three-factor five-level was applied to evaluate the optimization experiments. To the maximum percentage encapsulation efficiency (EE%) and minimum particle size (nm) of the Pae@PNCs, a quadratic polynomial model was generated to predict and evaluate the independent variables with respect to the dependent variables. RSM model goodness fitting were confirmed by the ANOVA Table ( P 2 and adjusted R 2 were close to 1, respectively) in good agreement with experimental values. By solving the regression equation and analyzing the response surface, three-dimensional model graphs and plots, the optimal result for the preparation of Pae@PNCs were found to be: pH (2.34), Poloxamer F-68 (0.80% m/v) and ethyl acetate/ α -BCA ratio (16.67 v/v) for the highest EE% (73.58 ± 2.76%) and the smallest particle size (42.06 ± 1.20 nm). The release profiles and antibacterial activity in vitro from the optimal Pae@PNCs were performed. The results indicated that it has slow and well-controlled release, and has strong antibacterial activity in vitro than paeonol. This understanding can help to predict the conditions of optimization of poly(butyl-2-cyanoacrylate) nanoparticles formation and to improve paeonol bioavailability and pharmacological properties. |
Databáze: | OpenAIRE |
Externí odkaz: |